MAPT and Alzheimer disease: Tau hyperphosphorylation, one of pathological hallmarks of AD, is also reduced by CBD treatment, as it reduces glycogen synthase kinase-3β, an enzyme responsible for tau hyperphosphorylation in patients with AD [67].